Shire, the maker of ADHD drugs Adderall XR and Vyvanse, had an excellent Q1 but now faces a challenge: Its two top products are threatened by a generic that Teva brought to market on April 2, BNet Pharma reports. Report [1]
Links:
[1] http://industry.bnet.com/pharma/10001923/shire-q1-the-big-fight-against-tevas-generics-begins/